BamSEC and AlphaSense Join Forces
Learn More

KalVista Pharmaceuticals Inc. – Indentures

NASDAQ: KALV    
Share price (4/10/26): $19.39    
Market cap (4/10/26): $980 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from 10-Q 83 pages KalVista Pharmaceuticals, Inc. 3.250% Convertible Senior Notes Due 2031 Indenture Dated as of September 29, 2025 U.S. Bank Trust Company, National Association, as Trustee
12/34/56
EX-4.1
from 8-K 104 pages KalVista Pharmaceuticals, Inc. 3.250% Convertible Senior Notes Due 2031 Indenture Dated as of September 29, 2025 U.S. Bank Trust Company, National Association, as Trustee
12/34/56
EX-4.2
from 10-K 4 pages Description of Registrant’s Securities
12/34/56
EX-4.3
from S-3 34 pages KalVista Pharmaceuticals, Inc. and , as Trustee Indenture Dated as of ,
12/34/56
EX-4.2
from S-3 5 pages Form of Debt Security
12/34/56
EX-4.1
from 10-Q 10 pages KalVista Pharmaceuticals, Inc. Form of Warrant to Purchase Common Stock
12/34/56
EX-4.1
from 8-K 9 pages KalVista Pharmaceuticals, Inc. Form of Warrant to Purchase Common Stock
12/34/56
EX-4.4
from S-3 34 pages KalVista Pharmaceuticals, Inc. and , as Trustee Indenture Dated as of ,
12/34/56
EX-4.3
from S-3 5 pages Form of Debt Security
12/34/56
EX-4.4
from S-3 34 pages KalVista Pharmaceuticals, Inc. and , as Trustee Indenture Dated as of ,
12/34/56
EX-4.3
from S-3 5 pages Form of Debt Security
12/34/56
EX-4.4
from S-3 34 pages KalVista Pharmaceuticals, Inc. and , as Trustee Indenture Dated as of ,
12/34/56
EX-4.3
from S-3 5 pages Form of Debt Security
12/34/56
EX-4.2
from S-1/A 2 pages Indenture or similar
12/34/56
EX-4.7
from S-1 13 pages Warrant to Purchase Stock
12/34/56
EX-4.6
from S-1 13 pages Warrant to Purchase Stock
12/34/56
EX-4.5.3
from S-1 2 pages Recitals Agreement
12/34/56
EX-4.5.2
from S-1 2 pages Recitals Agreement
12/34/56
EX-4.5.1
from S-1 12 pages Warrant to Purchase Stock
12/34/56
EX-4.4
from S-1 13 pages Warrant to Purchase Stock
12/34/56